H. Kim Lyerly

[Richard Schilsky @rschilsky]

Register now for the @AAADV_Workshop, Nov. 5-6. Go to https://t.co/5FsbaqO6Ps for program and registration.

[Richard Schilsky @rschilsky]

Visit https://t.co/5FsbaqO6Ps to register for the 2026 AAADV hybrid workshop to be held November 5-6 at Bethesda North Marriott.

[Richard Schilsky @rschilsky]

Save the Date and follow https://t.co/gNFs7UnUy5 for updates and registration.

[H. Kim Lyerly @HKimLyerly]

Excited to share these data from REPLICATE BIOSCIENCE validating the use of self replicating mRNA for vaccines. Duke Co-Founders Zach Hartman and Kim Lyerly, with Nathaniel Wang, Andrew Geall and Michael Ehlers are enthusiastic about the many applications of this technology!

[H. Kim Lyerly @HKimLyerly]

A nice note from a AAADV Workshop Alum:

Dear Prof. Lyerly
Best wishes for the success of the AAADV workshop. The workshop nicely helped my understand of the process of therapeutics development better. I
Dr. Vivek S Radhakrishnan, Senior Research Fellow

[H. Kim Lyerly @HKimLyerly]

Registration now open for the 2022 AAADV-ASCO-CDDF Global Cancer Drug Development Workshop

[H. Kim Lyerly @HKimLyerly]

https://t.co/8dKYt9LpY6

[H. Kim Lyerly @HKimLyerly]

2022 AAADV ASCO CDDF Global Cancer Drug Development Workshop https://t.co/9aF8y2c3RO

[Cindy Crowninshield @C_Crowninshield]

Leading experts at the May 3-5 2022 Bio-IT Conference & Expo discuss the cancer patient digital twin, a multi-institutional public-private technology initiative providing clinical decision support at the point of care to neuro oncology https://t.co/DAPIUBoIZT #BioIT22 @bioitworld

[H. Kim Lyerly @HKimLyerly]

Promising cancer vaccine in the works utilizing similar mRNA technology that combats COVID: Duke researchers https://t.co/YP69ze6Fwp via @YahooNews

[H. Kim Lyerly @HKimLyerly]

https://t.co/6w5MFtcWqT

[H. Kim Lyerly @HKimLyerly]

https://t.co/5PLhkv0JNd

[H. Kim Lyerly @HKimLyerly]

A

[Joshua Snyder @joshuacsnyder]

Way to go @josh_ginzel on a brilliant cover #Her2Crainbow @DukeDscb @DukeSurgery @DukeCellBiology

[Richard Schilsky @rschilsky]

Another great day at the @AAADV_Workshop with a fabulous keynote by former FDA Commissioner @califf001. Looking forward to tomorrow’s keynote by Sir Richard Peto and closing remarks by @DavidFajgenbaum.

[H. Kim Lyerly @HKimLyerly]

Higher Rates of Alzheimer’s Deaths, Hospitalizations Correlate with Air Pollution https://t.co/pWYbJU7M6O

[Richard Schilsky @rschilsky]

The @ASCO TAPUR Study model is being emulated in other countries. https://t.co/t4Vs6dMx8W

[H. Kim Lyerly @HKimLyerly]

Great work by Drs. Melinda Telli at Stanford and Erika Crobsy at Duke! Intratumoral plasmid IL-12 expands CD8+ T cells and induces a CXCR3 gene signature in triple-negative breast tumors… https://t.co/m74KlTUAIU

[H. Kim Lyerly @HKimLyerly]

Patient‐Reported Outcomes in Oncology Clinical Trials: Stakeholder Perspectives from the Accelerating Anticancer Agent Development and Validation Workshop 2019 https://t.co/h45YQ6cdf1

Congratulations Paul Kluetz and team for this thoughtful commentary!

[H. Kim Lyerly @HKimLyerly]

https://t.co/4wj1bxfoGj via @Hindawi
Recent study from the Environmental Health Scholars Program at Duke highlight health near concentrated animal feeding operations (CAFOs) in North Carolina.